Used as a key intermediate in the synthesis of antiviral and anticancer agents, particularly in the development of protease inhibitors. Its structure allows selective binding to enzyme active sites, making it valuable in pharmaceutical research. The compound's chiral centers and functional groups support optimization of drug potency and metabolic stability during lead compound development. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies targeting kinase and protease enzymes.